Lincoln Pharmaceuticals lost 2.93% to Rs 228.90 at 15:10 IST on BSE on profit booking after gaining 17.81% in the preceding eight trading sessions to settle at Rs 235.80 yesterday, 11 December 2017, from its close of Rs 200.15 on 29 November 2017.
Meanwhile, the BSE Sensex was down 244.22 points, or 0.73%, to 33,211.57. The BSE Small-Cap index was down 115.52 points, or 0.63%, to 18,136.25.
On the BSE, 1.71 lakh shares were traded in the counter so far, compared with an average volume of 32,908 shares in the past one quarter. The stock had hit a high of Rs 239.90 and a low of Rs 223.40 so far during the day. The stock had hit a 52-week high of Rs 256.20 on 29 March 2017. The stock had hit a 52-week low of Rs 148 on 11 August 2017.
The stock had outperformed the market over the past one month till 11 December 2017, rising 17.99% compared with the Sensex's 0.42% rise. The scrip also outperformed the market over the past one quarter, surging 49.76% as against the Sensex's 4.94% rise. The scrip also outperformed the market over the past one year, gaining 23.49% as against the Sensex's 25.08% rise.
The small-cap company has an equity capital of Rs 20 crore. Face value per share is Rs 10.
Also Read
On a consolidated basis, net profit of Lincoln Pharmaceuticals fell 56.9% to Rs 4.91 crore on 51.26% rise in net sales to Rs 134.86 crore in Q1 June 2017 over Q1 June 2016.
Lincoln Pharmaceuticals is engaged in manufacturing and exporting pharmaceuticals formulations under various therapeutic product group.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
